Literature DB >> 19889297

[Problems in defining melanoma regression and prognostic implication].

C Requena1, R Botella-Estrada, V Traves, E Nagore, S Almenar, C Guillén.   

Abstract

Between 10 % and 35 % of all melanomas show histological regression. That is, there is an area within the melanoma where the tumor retreats or disappears to be progressively replaced by fibrosis with presence of melanophages and variable degrees of inflammation, and neovascularization. Such regression is generally considered an indicator of poor prognosis in melanoma, although a number of studies contradict this affirmation. In this review, we summarize the leading articles about the influence of regression on melanoma prognosis. The results of these studies are very inconsistent, and so the prognostic significance of regression is somewhat controversial. We believe that some of these differences can be explained by differing criteria for regression and so we propose clear histological criteria to define early and sustained regression.

Entities:  

Mesh:

Year:  2009        PMID: 19889297

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  12 in total

Review 1.  Prognostic significance of autoimmunity during treatment of melanoma with interferon.

Authors:  Michal T Krauze; Ahmad Tarhini; Helen Gogas; John M Kirkwood
Journal:  Semin Immunopathol       Date:  2011-01-31       Impact factor: 9.623

Review 2.  Melanoma-associated leukoderma - immunology in black and white?

Authors:  Hadas Prag Naveh; Uma N M Rao; Lisa H Butterfield
Journal:  Pigment Cell Melanoma Res       Date:  2013-10-09       Impact factor: 4.693

3.  Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance.

Authors:  Phyu P Aung; Priyadharsini Nagarajan; Victor G Prieto
Journal:  Lab Invest       Date:  2017-02-27       Impact factor: 5.662

4.  Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma.

Authors:  Susannah E McClain; Amber L Shada; Megan Barry; James W Patterson; Craig L Slingluff
Journal:  Melanoma Res       Date:  2012-08       Impact factor: 3.599

5.  Multiple Primary Melanomas: Retrospective Review in a Tertiary Care Hospital.

Authors:  Rodolfo David Palacios-Diaz; Blanca de Unamuno-Bustos; Carlos Abril-Pérez; Mónica Pozuelo-Ruiz; Javier Sánchez-Arraez; Ignacio Torres-Navarro; Rafael Botella-Estrada
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

6.  Absence of Tumor-Infiltrating Lymphocyte Is a Reproducible Predictive Factor for Sentinel Lymph Node Metastasis: A Multicenter Database Study by the Brazilian Melanoma Group.

Authors:  João Pedreira Duprat; Eduard René Brechtbülh; Bianca Costa de Sá; Mauro Enokihara; Jose Humberto Fregnani; Gilles Landman; Marcus Maia; Felice Riccardi; Francisco Alberto Belfort; Alberto Wainstein; Luciana F Moredo; Higino Steck; Miguel Brandão; Marcelo Moreno; Eduardo Miranda; Ivan Dunshee de Oliveira Santos
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

7.  Regression and Sentinel Lymph Node Status in Melanoma Progression.

Authors:  Alina Florentina Letca; Loredana Ungureanu; Simona Corina Şenilă; Lavinia Elena Grigore; Ştefan Pop; Oana Fechete; Ştefan Cristian Vesa; Rodica Cosgarea
Journal:  Med Sci Monit       Date:  2018-03-06

8.  Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab.

Authors:  Raphael B Moreira; Lana Hamieh; Evisa Gjini; Ana Lako; Katherine M Krajewski; Charles H Yoon; Patrick A Ott
Journal:  J Immunother Cancer       Date:  2017-07-18       Impact factor: 13.751

9.  Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients.

Authors:  D Zugna; R Senetta; S Osella-Abate; M T Fierro; A Pisacane; A Zaccagna; A Sapino; V Bataille; A Maurichi; F Picciotto; P Cassoni; P Quaglino; S Ribero
Journal:  Br J Cancer       Date:  2017-11-09       Impact factor: 7.640

10.  Spontaneous regression of pulmonary metastatic melanoma.

Authors:  Sook Fen Ong; Michael Harden; Shabnam Irandoust; Richard Wai Wing Lee
Journal:  Respirol Case Rep       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.